Skip to main content
Clinical Trials/NCT01879150
NCT01879150
Unknown
Phase 1

Single Center, Open-label, Single Arm, Study Designed to Evaluate Safety, Tolerability and Efficacy of CyclaPlex Implant and Tools for Correction of First Inter-metatarsal Angle in Subjects Suffering From Hallux Valgus Deformity

Meir Medical Center1 site in 1 country10 target enrollmentJune 2013
ConditionsHallux Valgus

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hallux Valgus
Sponsor
Meir Medical Center
Enrollment
10
Locations
1
Primary Endpoint
Percent of subjects with 1st IMA ≤9º or reduction of more than 7º in the 1st IMA compared to Base line at last observed value (LOV).
Last Updated
12 years ago

Overview

Brief Summary

Single center, open-label, single arm, pilot study designed to evaluate safety, tolerability and efficacy of CYCLAPLEX device, a minimal invasive enhanced suture and button implant and surgery tools for correction of inter-metatarsal angle in subjects suffering from mild to moderate Hallux Valgus deformity

Detailed Description

INVESTIGATIONAL THERAPY Cycla Orthopedics Ltd has developed the CYCLAPLEX , a minimally invasive enhanced type of Suture and Button implant. It is intended to: (a) reduce the intermetatarsal angle (IMA) between 1MT and 2MT without osteotomy osteotomy b) reduce the risk of 2MT fractures (d) perform the implantation procedure in an easy and safe way. The CYCLAPLEX predicated device is the "Suture and Button" type MiniTightrope. It is based on Mini Tightrope clinical experience, however with additional features to increase safety and functionality. The CyclaPlex device comprise of two bone holders ('Anchors ') connected by a metal cord. The cord is connected to the buttons by crimp method as part of the surgery procedures The bone holders are T shape screws that are screwed into the bones after drilling holes across the 2 metatarsals. The gap in the bone as a result of the drilling is filled by the enhanced T shape buttons (screws). A nut is residing internally as part of the 1st met anchor structure. The IMA is reduced using specially designed tensioning tool CyclaPlex device is indicated for reducing intermetatarsal angles in cases where IMA is less than 200 eliminating the need for the traditional 1st metatarsal osteotomy. It used in conjunction with traditional release of the lateral MTP joint capsular structures and removal of the medial eminence as well as regular HVA reduction procedures such as AKIN. The 2nd Metatarsal fracture risk is reduced due multiple/ accumulated factors: (i) The hole drilled at 2nd metatarsal had been reduced significantly (ii) The hole is filled by conical screw and head. This firm anchoring method enable to distribute the horizontal forces applied during gate. (iii) The metal screw type device enables bone growth over it and strengthen the bone at that area. (iv) The connecting cord is housed inside the screw and has no direct touch with the bone, in both, 2nd and 1st metatarsals. The device is delivered sterilized ( steam sterilization) double bag residing in cardboard box. Dedicated assistive tools for multiple use are provided as well housed in a special tray intended for surgery room steam sterilization. The tools comprise of Aiming Drilling Guide,, screw driver for anchors insertion, Tensioning tool for reduction of the IMA, Crimping tool, cutter, single use drill bits

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
September 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percent of subjects with 1st IMA ≤9º or reduction of more than 7º in the 1st IMA compared to Base line at last observed value (LOV).

Time Frame: 6 months follow up and 12 months follow up

Secondary Outcomes

  • General Improvement as assessed by American Orthopaedic Foot and Ankle Society Hallux Metatarsophalangeal-lnterphalangeal Scale (AOFAS HMIS) score(6 months, 12 months)
  • Pain and Functional assessment [Foot Function Index (FFI)](6 months 12 months)
  • Time to full weight bear, to use of regular shoes and fashion shoes.(12 months)
  • Reduction in 1st IMA from baseline to LOV(6 months, 12 months)
  • Number and type of Adverse Events(6 months, 12 months)
  • Complications at surgery(3 months)

Study Sites (1)

Loading locations...

Similar Trials